Next Article in Journal
An Evaluation of the Behaviour-Change Techniques Used on Canadian Cancer Centre Web Sites to Support Physical Activity Behaviour for Breast Cancer Survivors
Previous Article in Journal
Survivorship Care Plans for Breast Cancer Patients: Understanding the Quality of the Available Evidence
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer

1
Department of Speech–Language Pathology, University of Toronto, Toronto, ON, Canada
2
Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada
3
Department of Otolaryngology–Head and Neck Surgery, University of Toronto, Toronto, ON, Canada
4
Department of Radiation Medicine, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5
Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
6
Department of Speech–Language Pathology, University Health Network, Toronto, ON, Canada
7
DeGroote School of Business, McMaster University, Burlington, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2017, 24(6), 466-476; https://doi.org/10.3747/co.24.3543
Submission received: 4 September 2017 / Revised: 3 October 2017 / Accepted: 6 November 2017 / Published: 1 December 2017

Abstract

Background: Resource limitations affect the intensity of speech–language pathology (SLP) dysphagia interventions for patients with head-and-neck cancer (HNC). The objective of the present study was to assess the feasibility of a prospective clinical trial that would evaluate the effects on health and patient costs of early SLP dysphagia intervention for HNC patients planned for curative concurrent chemoradiotherapy (CCRT). Methods: Patients with HNC planned for curative CCRT were consecutively recruited and received dysphagia-specific intervention before, during, and for 3 months after treatment. Swallowing function, body mass index, health-related quality of life (QOL), and out-of-pocket costs were measured before CCRT, at weeks 2 and 5 during CCRT, and at 1 and 3 months after CCRT. Actuarial percutaneous endoscopic gastrostomy (PEG) removal rates and body mass index in the study patients and in a time-, age-, and disease-matched cohort were compared. Results: The study enrolled 21 patients (mean age: 54 years; 19 men). The study was feasible, having a 95% accrual rate, 10% attrition, and near completion of all outcomes. Compared with the control cohort, patients receiving dysphagia intervention trended toward a higher rate of PEG removal at 3 months after CCRT [61% (32%–78%) vs. 53% (23%–71%), p = 0.23]. During CCRT, monthly pharmaceutical costs ranged between $239 and $348, with work loss in the range of 18–30 days for patients and 8–12 days for caregivers. Conclusions: We demonstrated the feasibility of comparing health and economic outcomes in patients receiving and not receiving early SLP dysphagia intervention. These preliminary findings suggest that early SLP dysphagia intervention for HNC patients might reduce PEG dependency despite worsening health. Findings also highlight effects on financial security for these patients and their caregivers.
Keywords: head-and-neck cancer; dysphagia interventions; patient costs; lost income; quality of life head-and-neck cancer; dysphagia interventions; patient costs; lost income; quality of life

Share and Cite

MDPI and ACS Style

Martino, R.; Ringash, J.; Durkin, L.; Greco, E.; Huang, S.H.; Xu, W.; Longo, C.J. Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer. Curr. Oncol. 2017, 24, 466-476. https://doi.org/10.3747/co.24.3543

AMA Style

Martino R, Ringash J, Durkin L, Greco E, Huang SH, Xu W, Longo CJ. Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer. Current Oncology. 2017; 24(6):466-476. https://doi.org/10.3747/co.24.3543

Chicago/Turabian Style

Martino, R., J. Ringash, L. Durkin, E. Greco, S. Hui Huang, W. Xu, and C. J. Longo. 2017. "Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer" Current Oncology 24, no. 6: 466-476. https://doi.org/10.3747/co.24.3543

APA Style

Martino, R., Ringash, J., Durkin, L., Greco, E., Huang, S. H., Xu, W., & Longo, C. J. (2017). Feasibility of Assessing Patient Health Benefits and Incurred Costs Resulting from Early Dysphagia Intervention during and Immediately after Chemoradiotherapy for Head-and-Neck Cancer. Current Oncology, 24(6), 466-476. https://doi.org/10.3747/co.24.3543

Article Metrics

Back to TopTop